We investigated the factors associated with development of a breakthrough infection, as well as hospitalization, and correlated them with the dynamics of anti-SARS-CoV-2 S1 IgG titers, as well as factors that might be associated with the decay. This evidence concerns the gene PSMD1 and infection.